Although GLP-1 patches are not currently licensed in the UK, the following guidance applies broadly to transdermal medication systems and would be relevant should such products become available
For many, caffeine causes a temporary spike in adrenaline, which can signal the liver to release stored glucose into the bloodstream
The pathobiology of diabetic complications: A unifying mechanism
The inhibition profile of methylene blue on nitrovasodilator induced cyclic guanosine monophosphate accumulation was quantitatively reproduced by extracellular generation of superoxide anion with xanthine (100 uM) and xanthine oxidase (5 mU)
Recommended injection sites include the abdomen (avoiding the area around the navel), the front and sides of the thighs, and the back of the upper arms
A Phase 2 clinical trial initiated in June 2024 is evaluating bremelanotide co-administered with a PDE5 inhibitor for men with erectile dysfunction unresponsive to PDE5 inhibitor monotherapy
